Compound ID |
Compound Name |
Compound Formula |
CP0030899
|
1-[(2-chlorophenyl)-diphenylmethyl]imidazole
Show/Hide
|
C22H17ClN2
|
1
|
1 |
IC50 = 16 nM
|
|
|
CP0036175
|
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate
Show/Hide
|
C37H48N6O5S2
|
1
|
1 |
IC50 = 16 nM
|
|
|
CP0041383
|
(3,5-dibromo-4-hydroxyphenyl)(2-ethyl-1-benzofuran-3-yl)methanone
Show/Hide
|
C17H12Br2O3
|
1
|
1 |
IC50 = 16 nM
|
|
|
CP0049135
|
4-Amino-N-(2-phenyl-2H-pyrazol-3-yl)-benzenesulfonamide
Show/Hide
|
C15H14N4O2S
|
1
|
1 |
IC50 = 200 nM
|
|
|
CP0057530
|
ECONAZOLE
Show/Hide
|
C18H15Cl3N2O
|
1
|
1 |
IC50 = 200 nM
|
|
|
CP0063077
|
1-[2-(2,4-dichlorobenzyl)oxy-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid
Show/Hide
|
C18H14Cl4N2O
|
1
|
1 |
IC50 = 200 nM
|
|
|
CP0072682
|
Exelderm
Show/Hide
|
C18H15Cl3N2S
|
1
|
1 |
IC50 = 200 nM
|
|
|
CP0062701
|
DANAZOL
Show/Hide
|
C22H27NO2
|
1
|
1 |
IC50 = 300 nM
|
|
|
CP0070834
|
3,3''''-methylenebis(4-hydroxy-coumarin
Show/Hide
|
C19H12O6
|
1
|
1 |
IC50 = 300 nM
|
|
|
CP0072374
|
BAY-E-5009
Show/Hide
|
C18H20N2O6
|
1
|
1 |
IC50 = 300 nM
|
|
|
CP0669560
|
Fluvastatin
Show/Hide
|
C24H26FNO4
|
1
|
1 |
IC50 = 400 nM
|
|
|
CP0042169
|
CHEBI:35847
Show/Hide
|
C14H9ClN2O3S
|
1
|
1 |
IC50 = 700 nM
|
|
|
CP0015320
|
BAY-E-9736
Show/Hide
|
C21H26N2O7
|
1
|
1 |
IC50 = 1000 nM
|
|
|
CP0016295
|
4-[4-(4-fluorophenyl)-2-(4-methanesulfinylphenyl)-1H-imidazol-5-yl]pyridine
Show/Hide
|
C21H16FN3OS
|
1
|
1 |
IC50 = 1000 nM
|
|
|
CP0069872
|
CAS_1508-75-4
Show/Hide
|
C17H20N2O2
|
1
|
1 |
IC50 = 1000 nM
|
|
|
CP0075172
|
2-(4-fluorophenyl)-4-methoxy-3-(pyridin-4-yl)-1H-pyrrolo[2,3-b]pyridin-6-amine
Show/Hide
|
C19H15FN4O
|
1
|
1 |
IC50 = 1000 nM
|
|
|
CP0077040
|
4-Amino-5-chloro-2-ethoxy-N-[4-(4-fluoro-benzyl)-morpholin-2-ylmethyl]-benzamide; citrate(AS-4370)
Show/Hide
|
C21H25ClFN3O3
|
1
|
1 |
IC50 = 1000 nM
|
|
|
CP0664135
|
1-(2-Methylbenzoyl)-4-(Phenylmethyl)-Piperidine
Show/Hide
|
C20H23NO
|
1
|
1 |
IC50 = 1000 nM
|
|
|
CP0671597
|
Stanozolol
Show/Hide
|
C21H32N2O
|
1
|
1 |
IC50 = 1127.6 nM
|
|
|
CP0002800
|
1-((p-(2-(5-chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea
Show/Hide
|
C23H28ClN3O5S
|
1
|
1 |
IC50 = 1602 nM
|
|
|
CP0000815
|
Rapamycin C-7, analog 4
Show/Hide
|
C51H79NO13
|
1
|
1 |
IC50 = 2000 nM
|
|
|
CP0041761
|
2-(4-hydroxyphenyl)-3-({4-[2-(piperidin-1-yl)ethoxy]phenyl}carbonyl)-1-benzothiophen-6-ol
Show/Hide
|
C28H27NO4S
|
1
|
1 |
IC50 = 2000 nM
|
|
|
CP0043937
|
(17beta-(N-tert-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one
Show/Hide
|
C23H36N2O2
|
1
|
1 |
IC50 = 2000 nM
|
|
|
CP0064411
|
N-[5-chloro-4-[(4-chlorophenyl)-cyanomethyl]-2-methylphenyl]-2-hydroxy-3,5-diiodobenzamide
Show/Hide
|
C22H14Cl2I2N2O2
|
1
|
1 |
IC50 = 2000 nM
|
|
|
CP0072749
|
3,5-Dibromo-N-(4-bromophenyl)-2-hydroxybenzamide (31)
Show/Hide
|
C13H8Br3NO2
|
1
|
1 |
IC50 = 2000 nM
|
|
|
CP0072895
|
US20230414632, Compound I-a
Show/Hide
|
C26H33NO6
|
1
|
1 |
IC50 = 2000 nM
|
|
|
CP0076992
|
4-benzyl-1-[(2-fluorophenyl)carbonyl]piperidine
Show/Hide
|
C19H20FNO
|
1
|
1 |
IC50 = 2000 nM
|
|
|
CP0663122
|
1-(2-Chlorobenzoyl)-4-(Phenylmethyl)-Piperidine
Show/Hide
|
C19H20ClNO
|
1
|
1 |
IC50 = 2000 nM
|
|
|
CP0669044
|
4-(Phenylmethyl)-1-[2-(Trifluoromethyl)Benzoyl]-Piperidine
Show/Hide
|
C20H20F3NO
|
1
|
1 |
IC50 = 2000 nM
|
|
|
CP0672250
|
1-(2-Methoxybenzoyl)-4-(Phenylmethyl)-Piperidine
Show/Hide
|
C20H23NO2
|
1
|
1 |
IC50 = 2000 nM
|
|
|
CP0045344
|
4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide
Show/Hide
|
C31H33N3O6S
|
1
|
1 |
IC50 = 2257.5 nM
|
|
|
CP0043276
|
CAS_114798-26-4
Show/Hide
|
C22H23ClN6O
|
1
|
1 |
IC50 = 2882 nM
|
|
|
CP0076413
|
DIHYDROERGOCRISTINE MESYLATE
Show/Hide
|
C36H45N5O8S
|
1
|
1 |
IC50 = 3000 nM
|
|
|
CP0094206
|
CHEBI:7825
Show/Hide
|
C18H13Cl4N3O
|
1
|
1 |
IC50 = 3000 nM
|
|
|
CP0114119
|
2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid(CV-11974)
Show/Hide
|
C24H20N6O3
|
1
|
1 |
IC50 = 3000 nM
|
|
|
CP0013042
|
(5R,5aR,8aR,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one
Show/Hide
|
C22H22O8
|
1
|
1 |
IC50 = 4000 nM
|
|
|
CP0048240
|
BDBM50101974
Show/Hide
|
C24H27NO5S
|
1
|
1 |
IC50 = 4000 nM
|
|
|
CP0049270
|
2-phenylethylhydrazine
Show/Hide
|
C8H12N2
|
1
|
1 |
IC50 = 4000 nM
|
|
|
CP0118647
|
(S)-2-(2-Benzoyl-phenylamino)-3-{4-[2-(methyl-pyridin-2-yl-amino)-ethoxy]-phenyl}-propionic acid
Show/Hide
|
C30H29N3O4
|
1
|
1 |
IC50 = 4000 nM
|
|
|
CP0082870
|
5-O-ethyl 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
Show/Hide
|
C18H19Cl2NO4
|
1
|
1 |
IC50 = 4579.5 nM
|
|
|
CP0070921
|
MLS001335996
Show/Hide
|
C76H52O46
|
1
|
1 |
IC50 = 4607.4 nM
|
|
|
CP0046612
|
CHEBI:31687
Show/Hide
|
C19H30O5
|
1
|
1 |
IC50 = 5000 nM
|
|
|
CP0047240
|
(6aR,9R)-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
Show/Hide
|
C32H41N5O5
|
1
|
1 |
IC50 = 6000 nM
|
|
|
CP0082578
|
CHEBI:27924
Show/Hide
|
C6H8N2
|
1
|
1 |
IC50 = 6000 nM
|
|
|
CP0041805
|
(E)-resveratrol
Show/Hide
|
C14H12O3
|
1
|
1 |
IC50 = 7000 nM
|
|
|
CP0669530
|
Nifursol
Show/Hide
|
C12H7N5O9
|
1
|
1 |
IC50 = 7000 nM
|
|
|
CP0044466
|
NOSCAPINE
Show/Hide
|
C22H23NO7
|
1
|
1 |
IC50 = 8177.3 nM
|
|
|
CP0041747
|
5071
Show/Hide
|
C24H32O4
|
1
|
1 |
IC50 = 10000 nM
|
|
|
CP0058647
|
BISACODYL
Show/Hide
|
C22H19NO4
|
1
|
1 |
IC50 = 10000 nM
|
|
|
CP0060773
|
CHEBI:31401
Show/Hide
|
C20H27N5O2
|
1
|
1 |
IC50 = 10000 nM
|
|
|